2Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,34:309-315.
1Makin A, Lip GY, Silverman S, et al. Peripheral vascular disease and hypertension: a forgotten association [ J ]? J Hum Hypertens, 2001,15 :447-454.
2Parikh A, Daneman D. Is carotid ultrasound a useful tool in assessing cardiovascular disease in individuals with diabetes[J] ? Diabetes Technol Ther, 2004,6:65-69.
3Jialal I, Devaraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker[J]. Am J Clin Pathol, 2001.116(Suppl) : S108-S115.
4European. Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension[ J ]. J Hypertens, 2003,21 : 1011-1053.
5Sasaki R, Yamano S,Yamamoto Y, et al. Vascular remodeling of the carotid artery in patients with untreated essential hypertension increases with age [ J ]. Hypertens Res, 2002,25 : 373 - 379.
6Zizek B, Poredos P, Dependence of morphological changes of the carotid arteries on essential hypertension and accompanying risk factors[J],Int Angiol, 2002,21 : 70-77.
7Saito M, Ishimitsu T, Minami J, et al. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors[J].Atherosclerosis, 2003,167: 73-79.
8Hajilooi M,Sanati A,Ahmadieh A,et al.Circulating ICAM-1,VCAM-1,E-selectin,P-selectin,and TNFRII in patients with coronary artery disease[J].Immunol Invest,2004,33 (3):263-275.
9Serban M,Tanaseanu C,Kosaka T,et al.Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent(type 2) diabetes mellitus[J].J Cell Mol Med,2002,6 (4):643-647.
